U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C5H9NO3
Molecular Weight 131.1299
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYDROXYPROLINE

SMILES

O[C@H]1CN[C@@H](C1)C(O)=O

InChI

InChIKey=PMMYEEVYMWASQN-DMTCNVIQSA-N
InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1

HIDE SMILES / InChI

Molecular Formula C5H9NO3
Molecular Weight 131.1299
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

HYDROXYPROLINE, a hydroxylated form of the imino acid proline, is a major component of the protein collagen. For this reason, HYDROXYPROLINE content in biological fluids is used as a parameter of collagen catabolism, especially bone resorption or tissue degradation. A deficiency in ascorbic acid can result in impaired HYDROXYPROLINE formation.

Approval Year

PubMed

PubMed

TitleDatePubMed
Prolidase-dependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts.
2010-12-15
Immunostimulatory activities of Bacillus simplex DR-834 to carp (Cyprinus carpio).
2010-09
The aberrance of the 4S diastereomer of 4-hydroxyproline.
2010-08-11
Essential modification of the Sircol Collagen Assay for the accurate quantification of collagen content in complex protein solutions.
2010-08
Thermodynamic consequences of incorporating 4-substituted proline derivatives into a small helical protein.
2010-05-18
Prolyl 4-hydroxylase.
2010-04
Quantum mechanical and NMR studies of ring puckering and cis/trans-rotameric interconversion in prolines and hydroxyprolines.
2009-10-08
Origin of the stability conferred upon collagen by fluorination.
2009-07-15
Stereoselective synthesis and biological evaluations of novel 3'-deoxy-4'-azaribonucleosides as inhibitors of hepatitis C virus RNA replication.
2009-07-09
Direct and continuous assay for prolyl 4-hydroxylase.
2009-03-15
Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis.
2008-11-30
Conformational preferences of substrates for human prolyl 4-hydroxylase.
2008-09-09
4-chloroprolines: synthesis, conformational analysis, and effect on the collagen triple helix.
2008-05
Extracellular matrix and HIF-1 signaling: the role of prolidase.
2008-03-15
Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls.
2008
Effects of glycosylation of (2S,4R)-4-hydroxyproline on the conformation, kinetics, and thermodynamics of prolyl amide isomerization.
2007-09-26
Nutraceuticals in the management of osteoarthritis.
2007-08
p53 activation by knockdown technologies.
2007-05-25
Oxaceprol--a randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug.
2007-04-10
Effects of dietary conjugated linoleic acid on production and metabolic parameters in transition dairy cows grazing fresh pasture.
2006-08
2005 Emil Thomas Kaiser Award.
2006-05
Dual mechanism of zinc-proline catalyzed aldol reactions in water.
2006-04-14
Conformational preference and cis-trans isomerization of 4(R)-substituted proline residues.
2006-02-02
Stereoelectronic effects on polyproline conformation.
2006-01
Stereoelectronic and steric effects in the collagen triple helix: toward a code for strand association.
2005-11-16
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
2005-10
Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability.
2005-07
The crystal structure of the collagen-like polypeptide (glycyl-4(R)-hydroxyprolyl-4(R)-hydroxyprolyl)9 at 1.55 A resolution shows up-puckering of the proline ring in the Xaa position.
2005-05-27
Adenosine postsynaptically modulates supraoptic neuronal excitability.
2005-01
O-acylation of hydroxyproline residues: effect on peptide-bond isomerization and collagen stability.
2005
Substituted 2-azabicyclo[2.1.1]hexanes as constrained proline analogues: implications for collagen stability.
2004-12-10
Prescription of drugs to pregnant women in France: the HIMAGE study.
2004-04-03
Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
2004-04
Evolutionary and functional implications of the complex glycosylation of Skp1, a cytoplasmic/nuclear glycoprotein associated with polyubiquitination.
2003-02
In vivo imaging approaches in animal models of rheumatoid arthritis.
2003
[Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis].
2002-11
Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance.
2002-09
Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women.
2002-08
Oxaceprol, an atypical inhibitor of inflammation, reduces leukocyte adherence in mouse antigen-induced arthritis.
2001-06
Measurement of histidinohydroxylysinonorleucine and hydroxyproline in skin collagen by reversed-phase high-performance liquid chromatography after 9-fluorenylmethyl chloroformate labeling.
1997-10-15
Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
1997-07
Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.
1996-07
Hydroxyproline and total protein levels in gingiva from patients treated with phenytoin and cyclosporine-A.
1996-03
Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in patients with juvenile, rapidly progressive, and adult periodontitis.
1993-05
Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in periodontally healthy human subjects.
1992-09
Quantitation of hydroxyproline isomers in acid hydrolysates by high-performance liquid chromatography.
1984-05-01
A criterion to determine whether cis-4-hydroxyproline is produced in animal tissues.
1984-03
Separation and evaluation of the cis and trans isomers of hydroxyprolines: effect of hydrolysis on the epimerization.
1984-02
Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
1979-03-15
Studies on bound trans-4-hydroxy-L-proline in sandal (Santalum album L.).
1970-10
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:49:13 GMT 2025
Edited
by admin
on Mon Mar 31 17:49:13 GMT 2025
Record UNII
RMB44WO89X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-46704
Preferred Name English
HYDROXYPROLINE
INCI   MI   WHO-DD  
INCI  
Official Name English
L-PROLINE, 4-HYDROXY-, (4R)-
Systematic Name English
4-HYDROXY-L-PROLINE
Systematic Name English
HYDROXYPROLINE [MI]
Common Name English
Hydroxyproline [WHO-DD]
Common Name English
(2S,4R)-4-HYDROXYPROLINE
Systematic Name English
HYP
Common Name English
L-HYDROXYPROLINE
Systematic Name English
4-HYDROXYPROLINE
Systematic Name English
LUMISTOR
Brand Name English
L-PROLINE, 4-HYDROXY-, TRANS-
Systematic Name English
Classification Tree Code System Code
LOINC 27181-7
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 2451-3
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 13374-4
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 56939-2
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 59392-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
NCI_THESAURUS C29596
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 53153-3
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 2445-5
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 13763-8
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
CFR 21 CFR 862.1400
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 15135-7
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 20647-4
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 17001-9
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 47651-5
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 2447-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 53154-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 26810-2
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 28601-3
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 13996-4
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 53393-5
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 11049-4
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 44386-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
DSLD 1137 (Number of products:1)
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 26740-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 53397-6
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 6710-8
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 2446-3
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 14785-0
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 25110-8
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
DSLD 1769 (Number of products:28)
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 59383-0
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 12720-9
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 53152-5
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 32250-3
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 25935-8
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 13401-5
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 26596-7
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 25934-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 15143-1
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
LOINC 32249-5
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
Code System Code Type Description
DRUG BANK
DB08847
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
RXCUI
1311548
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY RxNorm
CAS
6912-67-0
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
CHEBI
18095
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
CHEBI
18240
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
WIKIPEDIA
Hydroxyproline
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
EPA CompTox
DTXSID10883225
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
NSC
46704
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
DRUG CENTRAL
4272
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
CAS
51-35-4
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
SMS_ID
100000151964
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
CHEBI
20392
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
EVMPD
SUB126409
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
MESH
D006909
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
MERCK INDEX
m6148
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C76144
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-091-9
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
FDA UNII
RMB44WO89X
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
CHEBI
58419
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
DAILYMED
RMB44WO89X
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
PUBCHEM
5810
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
EVMPD
SUB129244
Created by admin on Mon Mar 31 17:49:14 GMT 2025 , Edited by admin on Mon Mar 31 17:49:14 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY